Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-02-20
1993-11-09
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544247, 544250, A61K 31505, C07D48714
Patent
active
052602982
ABSTRACT:
Imidazotriazoloquinazoline compounds having the general formula ##STR1## wherein A together with the .alpha.-marked carbon atom and the .beta.-marked nitrogen atom is one of the groups ##STR2## cyano or CO.sub.2 R.sup.5, wherein R.sup.5 is H, alkyl, cycloalkyl, trifluoromethyl or alkoxymethyl; and R.sup.2, R.sup.3 and R.sup.4 independently are H, hydroxy, halogen, CN, alkyl, alkenyl, alkynyl, trifluoromethyl, alkoxy, dialkylaminoalkoxy, aralkoxy, aryloxy which may be substituted, acyclic amino group, or NR.sup.6 R.sup.7, wherein R.sup.6 and R.sup.7 independently are H or alkyl.
The compounds are useful in psychopharmaceutical preparations as anticonvulsants, anxiolytics, hypnotics, antipsychotics, antiemetics, or in improving the cognitive function of the brain of mammals, or as benzodiazepine antagonsists.
REFERENCES:
patent: 4774245 (1988-09-01), Watjen et al.
patent: 5100895 (1992-03-01), Hansen et al.
Bernhardt Emily
Lowney Karen A.
Novo Nordisk A S
Zelson Steve T.
LandOfFree
Imidazatriazoloquinazoline compounds and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazatriazoloquinazoline compounds and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazatriazoloquinazoline compounds and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1142931